Drug comparisons
Saxagliptin vs Chlorpropamide
Compare Saxagliptin (DPP-4i) and Chlorpropamide (1st-gen SU) for diabetes. Saxagliptin has less hypoglycemia; chlorpropamide is outdated with higher risks.
No comparison dimensions are available for this page.
Clinical context
This comparison is triggered when considering a switch from an older sulfonylurea to a modern DPP-4 inhibitor in type 2 diabetes patients at hypoglycemia risk.
Bottom line
Saxagliptin generally offers a better safety profile than chlorpropamide, though neither is typically first-line therapy today.
All medication comparisons